BFLY vs HTFL vs NNNN Stock Comparison

Butterfly Network, Heartflow and Anbio Biotechnology Prices as of Oct 27, 2026 Peers: Industry group
BFLY Butterfly Network, Inc.
$7.40 -21.2% 1M +236.4% 1Y
Market cap
$2.05B
P/E
–
Revenue (TTM)
$112.15M
Div. yield
–
Diagnostic Equipment Healthcare
1 win
HTFL Heartflow, Inc.
$57.82 +17.6% 1M +50.8% 1Y
Market cap
$5.12B
P/E
–
Revenue (TTM)
$202.91M
Div. yield
–
Diagnostic Equipment Healthcare
5 wins
NNNN Anbio Biotechnology
$3.71 -41.1% 1M -84.5% 1Y
Market cap
$165.95M
P/E
25.3x
Revenue (TTM)
—
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

6 decided of 12

Heartflow leads on 5 of the 12 questions below (Heartflow 5, Butterfly Network 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYHTFLNNNNLeader
Larger companyMarket capitalisation $2.05B $5.12B $165.95M HTFL
Cheaper on earningsLower P/E, profitable companies only -27.3x -51.1x 25.3x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — — –
Faster revenue growthRevenue growth, trailing twelve months +28.1% +42.5% — HTFL
More profitableNet margin, trailing twelve months -66.7% -49.4% — HTFL
Better return on capitalReturn on invested capital — — — –
Less leveragedLower net debt / EBITDA — — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +236.4% +50.8% -84.5% BFLY
Better 5-year returnAnnualised price return, 5 years -6.3%/yr — — –
Less volatileAnnualised volatility, 1 year 114.8% 76.7% 135.9% HTFL
Higher overall scoreMean of the five percentile scores vs peers 45/100 57/100 — HTFL

Percentile Scorecard

BFLYHTFLNNNN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYHTFLNNNN
Valuation 28 #164 of 227 9 #207 of 227 20 #183 of 227
Growth 68 #71 of 219 78 #49 of 219 –
Profitability 32 #140 of 206 49 #106 of 206 –
Financial Health 61 #94 of 238 92 #20 of 238 100 #1 of 238
Shareholder Returns 37 #85 of 134 – –
Overall 45 57 –
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • HTFL ranked among 247 companies in Medical Devices and Diagnostics
  • NNNN ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYHTFLNNNNSPY
1 month -21.2%+17.6%-41.1% -0.2%
3 months +3.1%+125.9%-63.4% +3.9%
6 months +43.4%+89.3%-86.7% +8.2%
Year to date +94.7%+98.4%-87.7% +12.9%
1 year +236.4%+50.8%-84.5% +12.3%
3 years +836.7%—— +87.4%
3 years, per year +110.9%—— +23.3%
5 years -27.6%—— +67.9%
5 years, per year -6.3%—— +10.9%

Risk

MeasureBFLYHTFLNNNNSPY
Volatility, 1Y 114.8%76.7%135.9% 12.7%
Downside volatility, 1Y 91.7%77.5%136.2% 12.7%
Beta vs S&P 500, 1Y 3.001.900.26 1.00
Return / volatility, 1Y 2.060.66-0.62 0.97
Max drawdown, 5Y -93.4%-48.7%-94.0% -25.4%
From 52-week high -25.6%0.0%-91.0% -1.2%
52-week high $9.94$57.82$41.11 $779.14
52-week low $1.97$20.49$3.13 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYHTFLNNNN
P/E now vs peer median -25.9xmedian 29.6x -49.9xmedian 29.6x 25.3xmedian 29.6x
P/S now vs peer median 15.7xmedian 2.9x 24.7xmedian 2.9x 61.7xmedian 2.9x
EV/EBITDA now vs peer median -22.6xmedian 17.4x —median 17.4x —median 17.4x
P/FCF now vs peer median -62.8xmedian 22.3x —median 22.3x -79.2xmedian 22.3x
P/B now vs peer median 9.3xmedian 2.3x 17.9xmedian 2.3x 17.7xmedian 2.3x
PEG now vs peer median -0.96median 1.04 —median 1.04 —median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYHTFLNNNN
Revenue $112.15M $202.91M –
Gross profit $59.04M $160.45M –
Operating income -$79.38M -$64.46M –
Net income -$74.85M -$100.19M –
Free cash flow -$28.04M – –
R&D $38.10M $77.26M –
EPS (diluted) $-0.29 $-1.16 –
Cash & equivalents $124.66M $34.36M $7.77M
Shares (diluted) 262.10M 86.40M 43.67M
Enterprise value $1.49B $4.87B $119.17M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYHTFLNNNN
P/E -25.9x -49.9x 25.3x
P/FCF -62.8x – -79.2x
P/Operating cash flow -73.3x – –
P/S 15.7x 24.7x 61.7x
P/B 9.3x 17.9x 17.7x
P/Tangible book 9.6x 17.9x 17.7x
EV/EBITDA -22.6x – –
EV/EBIT -20.6x -74.0x –
EV/Revenue 14.6x 23.5x –
EV/FCF -58.4x – –
EV/Operating cash flow -68.1x – –
PEG (3Y EPS CAGR) -0.96 – –

Growth

14 metrics
MetricBFLYHTFLNNNN
Revenue growth (1Y) 28.1% 42.5% –
Revenue CAGR (3Y) 15.6% – –
Gross profit growth (1Y) 8.8% 48.8% –
Gross profit CAGR (3Y) 13.3% – –
Operating income growth (1Y) -14.8% -9.5% –
Operating income CAGR (3Y) 21.1% – –
Net income growth (1Y) -19.1% -18.3% –
Net income CAGR (3Y) 20.8% – –
EPS growth (1Y) -12.9% 91.4% –
EPS CAGR (3Y) 27.0% – –
Operating cash flow growth (1Y) 19.6% – –
Operating cash flow CAGR (3Y) 44.5% – –
Free cash flow growth (1Y) 12.2% – –
Free cash flow CAGR (3Y) 42.8% – –

Profitability

14 metrics
MetricBFLYHTFLNNNN
Gross margin 52.6% 79.1% –
EBITDA margin -64.4% – –
Operating margin -70.8% -31.8% –
Pretax margin -66.7% -49.4% –
Net margin -66.7% -49.4% –
FCF margin -25.0% – –
Operating cash flow margin -21.4% – –
Return on equity -39.3% -34.5% –
Return on assets -26.3% -28.5% –
Return on invested capital – – –
Return on capital employed -35.1% -20.9% –
Asset turnover 0.4x 0.6x –
Cash conversion (OCF / net income) 0.3x – –
Stock comp / revenue 21.3% 9.6% –

Financial Health

11 metrics
MetricBFLYHTFLNNNN
Debt / assets – – –
Debt / equity – – –
Net debt / EBITDA – – –
Debt / FCF – – –
Liabilities / assets 33.1% 18.8% 0.3%
Equity / assets 66.9% 81.2% 99.7%
Interest coverage -59.4x – –
Current ratio 4.1x 5.1x 344.3x
Quick ratio 2.7x 6.6x 177.1x
Cash ratio 2.1x 5.6x 135.5x
Altman Z-score 7.05 42.47 –

Shareholder Returns

7 metrics
MetricBFLYHTFLNNNN
Dividend yield – – –
Net buyback yield -0.4% – –
Shareholder yield -0.4% – –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYHTFLNNNN
EPS, next fiscal year $-0.10FY2026 $-0.43FY2026 –
Revenue, next fiscal year $114.50MFY2026 $261.38MFY2026 –
Revenue growth, next FY +17.3%FY2026 +48.5%FY2026 –
Revenue growth, the year after +26.0% +20.6% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYHTFLNNNN
Held by institutions 59.9% 100.0% 0.0%
Institutions holding 245 192 12
Change in shares held, QoQ +13.9% +133.0% +39.8%
Institutions buying 143 140 8
Institutions selling 59 38 3
Buyers to sellers 2.42 3.68 2.67

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYHTFLNNNN
BFLY 1.00 0.26 0.03
HTFL 0.26 1.00 -0.06
NNNN 0.03 -0.06 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, HTFL and NNNN?

Heartflow (HTFL) is the largest by market capitalisation: Butterfly Network (BFLY) $2.05B, Heartflow (HTFL) $5.12B, Anbio Biotechnology (NNNN) $165.95M.

Which company is growing faster?

Heartflow (HTFL) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +28.1%, Heartflow (HTFL) +42.5%.

Which company is more profitable?

Heartflow (HTFL) has the highest net margin (Butterfly Network (BFLY) -66.7%, Heartflow (HTFL) -49.4%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +236.4%, Heartflow (HTFL) +50.8%, Anbio Biotechnology (NNNN) -84.5%. Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Heartflow (HTFL) has been the steadiest (Butterfly Network (BFLY) 114.8%, Heartflow (HTFL) 76.7%, Anbio Biotechnology (NNNN) 135.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, HTFL and NNNN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Heartflow (HTFL) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.